20% Off for 5+ Items
Starting now, ending on Dec. 31st, enjoy 20% discount on 5 or more items storewide.
Up to 10 - color IHC Detection Kits
High-plex targeted protein panels,Complete assay solution, automation ready, with ability to customize
New Products
Comprehensive assay kits for drug screening
Featured Products
20% off for 5+ items
Enjoy 20% discount on 5 or more items storewide including OneStep ELISA Kits, mIHC Kits, IHC antibodies, Organoid Culture Kits, PTMs antibodies and so on.
Promo Period: 1 July 2026 to 31 Dec 2026
New Semester Launch | Spacial Biology
Discount Code: ANT2608@20
Promotion valid from 15 Aug to 31 Oct, 2026
About Us
AntBio - Fueling Research, Feeding Discovery
AntBio is a biotechnology group company dedicated to serving life sciences, aiming to help scientists accelerate research and improve work efficiency. AntBio provides comprehensive and high-quality reagent tools for basic research, drug development, and diagnosis, including research grade antibodies, proteins, biochemical reagents, and assay kits. These research tools are widely used in different segments of life science research. The group company currently consists of three brands, Absin, Starter-Bio and UA-Bio.
50k
Happy Clients
100k
Products
70+
Doctor/Expert
20,000+
Publications
ARTICLES
Latest News
Systematic Validation of An...
This bioprocess‑QA technical review covers systematic antibody batch‑consistency validation workflows, physicochemical‑characterization, primary/higher‑order‑structure analysis, biological‑activity assays, accelerated‑long‑term stability testing and statistical acceptance‑criteria setting. It introduces antibody batch‑stability evaluation services from ANT...
Systematic Validation of An...
This bioprocess‑QA technical review covers systematic antibody batch‑consistency validation workflows, physicochemical‑characterization, primary/higher‑order‑structure analysis, biological‑activity assays, accelerated‑long‑term stability testing and statistical...
View Details
Custom Anti‑HER2 Antibodies: Speciali...
This oncology‑biotech review explains ERBB2/HER2 receptor‑tyrosine‑kinase molecular biology, extracellular‑domain epitope‑guided antibody‑design principles, multi‑dimensional functional‑validation workflows and broad use‑cases including IHC biomarker‑profiling, flow‑cytometry, ADC‑biosimilar‑preclinical basic‑research. It introduces end‑to‑end custom anti‑HER2 antibody...
Custom Anti‑HER2 Antibodies: Speciali...
This oncology‑biotech review explains ERBB2/HER2 receptor‑tyrosine‑kinase molecular biology, extracellular‑domain epitope‑guided antibody‑design principles, multi‑dimensional functional‑validation workflows and broad use‑cases including IHC...
View Details
Custom Immunology‑Focused Antibodies:...
This immunology‑tool review explains custom immunology‑antibody development workflows, target‑category profiles (immune‑cell‑markers, immune‑checkpoints, cytokines‑chemokines, phospho‑signalling‑transduction targets), multi‑dimensional functional‑validation assays and common experimental pitfalls. It introduces end‑to‑end immunology‑custom‑antibody development services from ANT...
Custom Immunology‑Focused Antibodies:...
This immunology‑tool review explains custom immunology‑antibody development workflows, target‑category profiles (immune‑cell‑markers, immune‑checkpoints, cytokines‑chemokines, phospho‑signalling‑transduction targets), multi‑dimensional functional‑validation assays and common...
View Details
GSPT1/eRF3: Translation‑Termination F...
This targeted‑protein‑degradation review interprets GSPT1/eRF3 translation‑termination biological roles, molecular‑glue degrader CC‑885‑driven CRBN‑GSPT1 ternary‑complex formation, glioblastoma xenograft in‑vivo phenotypes, KO‑rescue apoptosis‑related observations and HTRF biochemical‑assay workflows. It provides anti‑GSPT1 antibody, CRBN‑complex,...
GSPT1/eRF3: Translation‑Termination F...
This targeted‑protein‑degradation review interprets GSPT1/eRF3 translation‑termination biological roles, molecular‑glue degrader CC‑885‑driven CRBN‑GSPT1 ternary‑complex formation, glioblastoma xenograft in‑vivo phenotypes, KO‑rescue apoptosis‑related...
View Details